NCT00310154View on ClinicalTrials.gov

Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

July 31, 2007

Study Completion Date

August 31, 2010

Conditions
Lung Cancer
Interventions
DRUG

docetaxel

DRUG

gefitinib

OTHER

laboratory biomarker analysis

RADIATION

radiation therapy

Trial Locations (1)

27157-1082

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00310154 - Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter